These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8901945)

  • 21. Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig.
    Fechter LD; Liu Y; Pearce TA
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):47-55. PubMed ID: 9007033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KR-31378 protects neurons from ischemia-reperfusion brain injury by attenuating lipid peroxidation and glutathione loss.
    Kim SO; Cho IS; Gu HK; Lee DH; Lim H; Yoo SE
    Eur J Pharmacol; 2004 Mar; 487(1-3):81-91. PubMed ID: 15033379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.
    Holmquist L; Stuchbury G; Berbaum K; Muscat S; Young S; Hager K; Engel J; Münch G
    Pharmacol Ther; 2007 Jan; 113(1):154-64. PubMed ID: 16989905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why should you care about free radicals?
    Pierce JD; Cackler AB; Arnett MG
    RN; 2004 Jan; 67(1):38-42; quiz 43. PubMed ID: 14979192
    [No Abstract]   [Full Text] [Related]  

  • 25. A rational approach to antioxidant therapy and vitamin E.
    Hyman M; Pizzorno J; Weil A
    Altern Ther Health Med; 2005; 11(1):14-7. PubMed ID: 15712759
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.
    Hall ED; Andrus PK; Smith SL; Fleck TJ; Scherch HM; Lutzke BS; Sawada GA; Althaus JS; Vonvoigtlander PF; Padbury GE; Larson PG; Palmer JR; Bundy GL
    J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin oxidative stress and neurodegenerative diseases.
    Srinivasan V
    Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
    Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
    Hyakkoku K; Nakajima Y; Izuta H; Shimazawa M; Yamamoto T; Shibata N; Hara H
    Neuroscience; 2009 Mar; 159(2):760-9. PubMed ID: 19166916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson's disease?
    Youdim MB; Geldenhuys WJ; Van der Schyf CJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S281-91. PubMed ID: 18267251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroprotective agents].
    Yonehara T
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():54-8. PubMed ID: 17469534
    [No Abstract]   [Full Text] [Related]  

  • 33. Basic principles of cerebral protection in humans.
    Lanier WL
    Liver Transpl Surg; 1999 Jul; 5(4):347-9. PubMed ID: 10388512
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral supplementation of Majun Baladar ameliorates antioxidant enzyme activities in cerebral ischaemic damage.
    Yousuf S; Atif F; Hoda N; Ahmad M; Saleem S; Ishrat T; Khan MB; Ahmad AS; Islam F
    Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):246-53. PubMed ID: 17845506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in studies on neuroprotective agents].
    Liu GQ
    Yao Xue Xue Bao; 2002 Aug; 37(8):657-62. PubMed ID: 12567785
    [No Abstract]   [Full Text] [Related]  

  • 36. Should we treat concussion pharmacologically? The need for evidence based pharmacological treatment for the concussed athlete.
    McCrory P
    Br J Sports Med; 2002 Feb; 36(1):3-5. PubMed ID: 11867481
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of experimental acute tubular necrosis: current clinical applications and perspectives.
    Verbeke M; Van de Voorde J; Lameire N
    Adv Nephrol Necker Hosp; 1996; 25():177-216. PubMed ID: 8717627
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological neuroprotection during cardiac surgery.
    Kadoi Y
    Asian Cardiovasc Thorac Ann; 2007 Apr; 15(2):167-77. PubMed ID: 17387205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are the reactive oxygen-derived species (ROS) interactive properties of the many therapeutic drugs from various categories pertinent to their beneficial effects?
    Cash CD
    Gen Pharmacol; 1997 Feb; 28(2):169-75. PubMed ID: 9013190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaesthetic neuroprotection in children: does it exist or is it all just bad?
    Marchesini V; Disma N
    Curr Opin Anaesthesiol; 2019 Jun; 32(3):363-369. PubMed ID: 30893117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.